(Q45079498)

9 December 2017

Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC. (English)

1 reference

9 December 2017

1 reference

5

1 reference

9 December 2017

Guadalupe Soria

1

1 reference

9 December 2017

Anna Castañé

2

1 reference

9 December 2017

Fernando Berrendero

3

1 reference

9 December 2017

Catherine Ledent

4

1 reference

9 December 2017

Rafael Maldonado

6

1 reference

9 December 2017

Olga Valverde

7

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

European Journal of Neuroscience

9 December 2017

1 reference

9 December 2017

20

1 reference

9 December 2017

8

1 reference

9 December 2017

2203-2213

1 reference

The effects of cannabinoids on the brain

9 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Increase of morphine withdrawal in mice lacking A2a receptors and no changes in CB1/A2a double knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Nucleus accumbens shell and core dopamine: differential role in behavior and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Evidence for adenosine/dopamine receptor interactions: indications for heteromerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Modulation of feeding behaviour by blocking purinergic receptors in the rat nucleus accumbens: a combined microdialysis, electroencephalographic and behavioural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Pharmacological and biochemical interactions between opioids and cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Effects of an adenosine A2A receptor blockade in the nucleus accumbens on locomotion, feeding, and prepulse inhibition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

The molecular logic of endocannabinoid signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Adenosine A(2) receptors inhibit morphine self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Distribution, biochemistry and function of striatal adenosine A2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Effects of selective adenosine A1 and A2a agonists on amphetamine-induced locomotion and c-Fos in striatum and nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Observational analysis of feeding induced by Delta9-THC and anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Hyperphagia in pre-fed rats following oral delta9-THC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-βγ dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03682.X

10.1111/J.1460-9568.2004.03682.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference